miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma

To identify 'melanoma-specific' microRNAs (miRNAs) we used an unbiased microRNA profiling approach to comprehensively study cutaneous melanoma in relation to other solid malignancies, which revealed 233 differentially expressed (≥ 2 fold, p < 0.05) miRNAs. Among the top 20 most signific...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget 2015-07, Vol.6 (19), p.17753-17763
Main Authors: Stark, Mitchell S, Bonazzi, Vanessa F, Boyle, Glen M, Palmer, Jane M, Symmons, Judith, Lanagan, Catherine M, Schmidt, Christopher W, Herington, Adrian C, Ballotti, Robert, Pollock, Pamela M, Hayward, Nicholas K
Format: Article
Language:English
Subjects:
Antineoplastic Agents - pharmacology
Blotting, Western
Cell Line, Tumor
Gene Expression Profiling
Gene Expression Regulation, Neoplastic - genetics
Genes, Tumor Suppressor
Humans
Indoles - pharmacology
Melanoma - genetics
Melanoma - metabolism
Melanoma - pathology
MicroRNAs - genetics
Mutagenesis, Site-Directed
Neurofibromin 1 - biosynthesis
Neurofibromin 1 - genetics
Oligonucleotide Array Sequence Analysis
Polymerase Chain Reaction
Proto-Oncogene Proteins B-raf - metabolism
Research Paper
Sulfonamides - pharmacology
Transfection
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To identify 'melanoma-specific' microRNAs (miRNAs) we used an unbiased microRNA profiling approach to comprehensively study cutaneous melanoma in relation to other solid malignancies, which revealed 233 differentially expressed (≥ 2 fold, p < 0.05) miRNAs. Among the top 20 most significantly different miRNAs was hsa-miR-514a-3p. miR-514a is a member of a cluster of miRNAs (miR-506-514) involved in initiating melanocyte transformation and promotion of melanoma growth. We found miR-514a was expressed in 38/55 (69%) melanoma cell lines but in only 1/34 (3%) other solid cancers. To identify miR-514a regulated targets we conducted a miR-514a-mRNA 'pull-down' experiment, which revealed hundreds of genes, including: CTNNB1, CDK2, MC1R, and NF1, previously associated with melanoma. NF1 was selected for functional validation because of its recent implication inacquired resistance to BRAFV600E-targeted therapy. Luciferase-reporter assays confirmed NF1 as a direct target of miR-514a and over-expression of miR-514a in melanoma cell lines inhibited NF1 expression, which correlated with increased survival of BRAFV600E cells treated with PLX4032. These data provide another mechanism for the dysregulation of the MAPK pathway which may contribute to the profound resistance associated with current RAF-targeted therapies.
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.3924